3B6Z

Lovastatin polyketide enoyl reductase (LovC) complexed with 2'-phosphoadenosyl isomer of crotonoyl-CoA

X-RAY DIFFRACTION

Crystallization

Crystalization Experiments
ID	Method	pH	Temperature	Details
1	VAPOR DIFFUSION, SITTING DROP	6.9	298	24% PEG 3350, 0.1 M Tris-HCl, 0.2 M NaCl, pH 6.9, VAPOR DIFFUSION, SITTING DROP, temperature 298K

Crystal Properties
Matthews coefficient	Solvent content
2.57	52.18

Crystal Data

Unit Cell
Length ( Å )	Angle ( ˚ )
a = 44.334	α = 90
b = 54.867	β = 90
c = 171.82	γ = 90

Symmetry
Space Group	P 21 21 21

Diffraction

Diffraction Experiment
ID #	Crystal ID	Scattering Type	Data Collection Temperature	Detector	Detector Type	Details	Collection Date	Monochromator	Protocol
1	1	x-ray	100	CCD	ADSC QUANTUM 315	mirrors	2006-09-09	M	SINGLE WAVELENGTH
2	1	x-ray		CCD	ADSC QUANTUM 315	mirrors	2006-10-11	M	MAD

Radiation Source
ID #	Source	Type	Wavelength List	Synchrotron Site	Beamline
1	SYNCHROTRON	ALS BEAMLINE 5.0.2	1.0000	ALS	5.0.2
2	SYNCHROTRON	ALS BEAMLINE 5.0.2	0.9803, 0.9806, 0.9184	ALS	5.0.2

Data Collection

Overall
ID #	Resolution (High)	Resolution (Low)	Percent Possible (Observed)	R Sym I (Observed)	Net I Over Average Sigma (I)	Redundancy	Number Reflections (All)	Number Reflections (Observed)	Observed Criterion Sigma (F)	Observed Criterion Sigma (I)	B (Isotropic) From Wilson Plot
1,2	1.88	50	94.5	0.096	20.2	6.1	32881	31043

Highest Resolution Shell
ID #	Resolution (High)	Resolution (Low)	Percent Possible (All)	Percent Possible (Observed)	R-Sym I (Observed)	Mean I Over Sigma (Observed)	Redundancy	Number Unique Reflections (All)
1,2	1.9	1.97	71.8		0.453	2.2	4.8	2454

Refinement

Statistics
Diffraction ID	Structure Solution Method	Cross Validation method	Resolution (High)	Resolution (Low)	Number Reflections (All)	Number Reflections (Observed)	Number Reflections (R-Free)	Percent Reflections (Observed)	R-Factor (All)	R-Work	R-Free	R-Free Selection Details	Mean Isotropic B
X-RAY DIFFRACTION	MAD	THROUGHOUT	1.88	39.62	34424	30999	3115	90.05	0.176	0.171	0.221	RANDOM	33.82

Temperature Factor Modeling
Anisotropic B[1][1]	Anisotropic B[1][2]	Anisotropic B[1][3]	Anisotropic B[2][2]	Anisotropic B[2][3]	Anisotropic B[3][3]
-0.12			0.5		-0.37

RMS Deviations
Key	Refinement Restraint Deviation
r_dihedral_angle_2_deg	36.887
r_dihedral_angle_4_deg	17.739
r_dihedral_angle_3_deg	16.353
r_dihedral_angle_1_deg	7.039
r_scangle_it	5.13
r_scbond_it	3.452
r_mcangle_it	2.085
r_angle_refined_deg	1.618
r_mcbond_it	1.35
r_symmetry_hbond_refined	0.317

RMS Deviations
Key	Refinement Restraint Deviation
r_dihedral_angle_2_deg	36.887
r_dihedral_angle_4_deg	17.739
r_dihedral_angle_3_deg	16.353
r_dihedral_angle_1_deg	7.039
r_scangle_it	5.13
r_scbond_it	3.452
r_mcangle_it	2.085
r_angle_refined_deg	1.618
r_mcbond_it	1.35
r_symmetry_hbond_refined	0.317
r_nbtor_refined	0.308
r_nbd_refined	0.215
r_symmetry_vdw_refined	0.198
r_xyhbond_nbd_refined	0.155
r_chiral_restr	0.113
r_bond_refined_d	0.015
r_gen_planes_refined	0.006

Non-Hydrogen Atoms Used in Refinement
Non-Hydrogen Atoms	Number
Protein Atoms	2706
Nucleic Acid Atoms
Solvent Atoms	220
Heterogen Atoms	59

Software

Software
Software Name	Purpose
REFMAC	refinement
HKL-2000	data reduction
HKL-2000	data scaling
SOLVE	phasing

RCSB PDB Core Operations are funded by the National Science Foundation (DBI-1832184), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.